X-40072655-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_StrongBP6_ModerateBP7BS1BS2
The NM_001123385.2(BCOR):āc.2691G>Cā(p.Ser897Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000895 in 1,210,444 control chromosomes in the GnomAD database, including 12 homozygotes. There are 339 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ).
Frequency
Genomes: š 0.00089 ( 0 hom., 38 hem., cov: 24)
Exomes š: 0.00090 ( 12 hom. 301 hem. )
Consequence
BCOR
NM_001123385.2 synonymous
NM_001123385.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.51
Genes affected
BCOR (HGNC:20893): (BCL6 corepressor) The protein encoded by this gene was identified as an interacting corepressor of BCL6, a POZ/zinc finger transcription repressor that is required for germinal center formation and may influence apoptosis. This protein selectively interacts with the POZ domain of BCL6, but not with eight other POZ proteins. Specific class I and II histone deacetylases (HDACs) have been shown to interact with this protein, which suggests a possible link between the two classes of HDACs. Several transcript variants encoding different isoforms have been found for this gene. A pseudogene of this gene is found on chromosome Y.[provided by RefSeq, Jun 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant X-40072655-C-G is Benign according to our data. Variant chrX-40072655-C-G is described in ClinVar as [Benign]. Clinvar id is 533719.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chrX-40072655-C-G is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-3.51 with no splicing effect.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.000891 (100/112238) while in subpopulation EAS AF= 0.0272 (97/3564). AF 95% confidence interval is 0.0228. There are 0 homozygotes in gnomad4. There are 38 alleles in male gnomad4 subpopulation. Median coverage is 24. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 38 XL gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000891 AC: 100AN: 112183Hom.: 0 Cov.: 24 AF XY: 0.00111 AC XY: 38AN XY: 34349
GnomAD3 genomes
AF:
AC:
100
AN:
112183
Hom.:
Cov.:
24
AF XY:
AC XY:
38
AN XY:
34349
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00233 AC: 427AN: 183433Hom.: 2 AF XY: 0.00199 AC XY: 135AN XY: 67883
GnomAD3 exomes
AF:
AC:
427
AN:
183433
Hom.:
AF XY:
AC XY:
135
AN XY:
67883
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000895 AC: 983AN: 1098206Hom.: 12 Cov.: 30 AF XY: 0.000828 AC XY: 301AN XY: 363566
GnomAD4 exome
AF:
AC:
983
AN:
1098206
Hom.:
Cov.:
30
AF XY:
AC XY:
301
AN XY:
363566
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000891 AC: 100AN: 112238Hom.: 0 Cov.: 24 AF XY: 0.00110 AC XY: 38AN XY: 34414
GnomAD4 genome
AF:
AC:
100
AN:
112238
Hom.:
Cov.:
24
AF XY:
AC XY:
38
AN XY:
34414
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
BCOR-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 05, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Oculofaciocardiodental syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 20, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at